412.7
-10.15 (-2.40%)
GUJTHEM • 21 Nov, 2025 | 03:29 PM
Gujarat Themis Biosyn Stock Performance
|
|
|
Gujarat Themis Biosyn Company background
Founded in: 1981
Managing director: Sachin D Patel
Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG) a unique consortium of five competing drug companies Themis Medicare Ltd., Kopran Ltd., Anant Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990. However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990. Subsequently, Company was taken over by a group consisting of Lyka Labs, Themis Chemicals, Kopran and Cadila. Also, Yuhan Corp., South Korea, brought in technology and finance for running GTBL.During 199596 the paidup share capital increased from Rs 11.25 crores to Rs 11.60 crores after allotment of 350,000 Equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions by way of conversion of fund interst term loan. During the year 201920, installed capacity of rifamysinS was increased to 90 mtpa and expansion of rifampicin was achieved to the maximum capacity of 120 mtpa. It also commenced operations of its new pharmaceutical division and launched a wide range of antituberculosis products and other antibiotics in 2022.Company is presently engaged in the manufacturing of fermentationbased pharmaceutical intermediates and APIs. It is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin. The Company commenced its commercial production at its newly set up API Plant situated at 69/C, GIDC Industrial Estate, Vapi, in Valsad district of Gujarat with effect from 6 May, 2025. The multipurpose synthetic and fermentationbased API plant has been established for the production of various Active Pharmaceutical Ingredients (APIs) and Intermediates for use in the pharmaceutical industry.
Gujarat Themis Biosyn Financial Highlights
As of Sep '25, Gujarat Themis Biosyn’s market capitalisation stood at ₹4,497.00 crores.
Shareholding as of Sep '25 shows promoters holding 70.9%, with FIIs at
3%, DIIs at 1.1%, and public at 25%.
Gujarat Themis Biosyn Share Price Today
As of 23 Nov 2025, Gujarat Themis Biosyn share price is ₹412.8. The stock opened at ₹422.8 and had closed at ₹422.8 the previous day. During today’s trading session, Gujarat Themis Biosyn share price moved between ₹406.40 and ₹423.05, with an average price for the day of ₹414.73. Over the last 52 weeks, the stock has recorded a low of ₹208.00 and a high of ₹479.00. In terms of performance, Gujarat Themis Biosyn share price has increased by 30.7% over the past six months and has increased by 58.79% over the last year.
Gujarat Themis Biosyn Fundamental
Market Cap (in crs)
4,497.00
Face Value
1
Turnover (in lacs)
521.49
Key Metrics
Qtr Change %
114.58% Gain from 52W Low
3.3
Dividend yield 1yr %
Low in industry
0.2
Gujarat Themis Biosyn Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
412.7
Current Price
Day EMA5
427.90
Day EMA10
436.50
Day EMA12
438.30
Day EMA20
440.50
Day EMA26
439.10
Day EMA50
426.90
Day EMA100
400.70
Day EMA200
366.60
Day SMA5
431.00
Day SMA10
440.50
Day SMA20
450.70
Day SMA30
444.40
Day SMA50
426.20
Day SMA100
397.00
Day SMA150
369.10
Day SMA200
342.40
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 73113 Rs | 131068 Rs |
Week Rs | 70932 Rs | 124223 Rs |
Month Rs | 93890 Rs | 153871 Rs |
Resistance & Support
414.75
Pivot
Resistance
First Resistance
421.50
Second Resistance
430.25
Third Resistance
437
Support
First Support
406
Second support
399.25
Third Support
390.50
Relative Strength Index
33.96
Money Flow Index
20.33
MACD
-0.80
MACD Signal
5.51
Average True Range
15.50
Average Directional Index
25.88
Rate of Change (21)
-9.85
Rate of Change (125)
36.42
Gujarat Themis Biosyn Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
866.40 | 4,394.30 | 603.8 | 1997.4 | 869.70 | 7.80% | 18.73% | 17.41% | -41.36% | 116.57% | 0.00% | 60.84 | 41.32 | 3.27 | |
136.01 | 4,413.82 | 109.3 | 241 | 138.06 | 2.98% | 3.19% | -17.96% | -28.54% | -44.76% | 0.00% | 0.00 | 41.32 | -12.65 | |
238.73 | 6,038.66 | 117.35 | 257.85 | 239.62 | 4.21% | 16.07% | 33.57% | 23.97% | 161.34% | 0.00% | 384.76 | 41.32 | 5.11 | |
412.70 | 4,497.00 | 208 | 479 | 422.85 | -7.65% | -9.94% | 31.77% | 42,446.39% | 42,446.39% | 0.16% | 93.17 | 41.32 | 17.01 | |
1,685.10 | 5,111.36 | 540 | 1740 | 1,669.70 | 5.51% | 4.98% | 68.46% | 207.61% | 544.52% | 0.06% | 249.28 | 41.32 | 11.22 | |
743.10 | 5,980.68 | 556.15 | 842 | 772.75 | -5.90% | -1.47% | 3.83% | 5.64% | 204.11% | 0.13% | 32.82 | 41.32 | 5.53 |
Gujarat Themis Biosyn Share Price FAQs
What is Share Price of Gujarat Themis Biosyn ?
Gujarat Themis Biosyn share price is ₹412.7 in NSE and ₹412.75 in BSE as on 21/11/2025.
How has Gujarat Themis Biosyn shares performed in the past ?
Gujarat Themis Biosyn share price in the past 1-year return was 42446.39. The Gujarat Themis Biosyn share hit a 1-year low of Rs. 208 and a 1-year high of Rs. 479.
What is the market cap of Gujarat Themis Biosyn ?
The market cap of Gujarat Themis Biosyn is Rs. 4497 Cr. as of 21/11/2025.
What is the current P/E ratio of Gujarat Themis Biosyn ?
The PE ratios of Gujarat Themis Biosyn is 93.17 as of 21/11/2025.
What is the current PB ratio of Gujarat Themis Biosyn ?
The PB ratios of Gujarat Themis Biosyn is 17 as of 21/11/2025
What is the Mutual Fund shareholding in Gujarat Themis Biosyn ?
The Mutual Fund Shareholding in Gujarat Themis Biosyn was 1.16% at the end of 21/11/2025.
How to buy Gujarat Themis Biosyn shares?
You can easily buy Gujarat Themis Biosyn shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Gujarat Themis Biosyn ?
The 52-week high and low of Gujarat Themis Biosyn share price is ₹479 and ₹208 as of 21/11/2025.
Please be aware that Gujarat Themis Biosyn stock prices are subject to continuous fluctuations due to various factors.
Invest in Gujarat Themis Biosyn